Have your own idea? Try our Stock Screener
The Biotech industry has stayed flat over the last week. The past year has been better, since the industry has gained 27% in that time. Earnings are forecast to grow by 28% annually.
Has the U.S. Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Sun, 20 Oct 2024 | US$908.0b | US$113.1b | -US$35,950,283,773.02 | 21.7x | -25.3x | 8x |
Tue, 17 Sep 2024 | US$932.2b | US$113.2b | -US$35,921,970,608.82 | 23.6x | -26x | 8.2x |
Thu, 15 Aug 2024 | US$874.6b | US$113.2b | -US$36,248,323,495.67 | 21.4x | -24.1x | 7.7x |
Sat, 13 Jul 2024 | US$1.2t | US$164.5b | -US$28,119,687,665.65 | 29.4x | -42.2x | 7.2x |
Mon, 10 Jun 2024 | US$1.2t | US$164.5b | -US$26,798,622,131.21 | 28.1x | -43.1x | 7x |
Wed, 08 May 2024 | US$1.1t | US$163.1b | -US$27,148,218,752.30 | 25.7x | -41.4x | 6.9x |
Fri, 05 Apr 2024 | US$1.1t | US$164.3b | -US$23,437,244,791.39 | 23.1x | -48.9x | 7x |
Sun, 03 Mar 2024 | US$1.2t | US$167.9b | -US$21,319,237,627.75 | 15.9x | -56.5x | 7.2x |
Tue, 30 Jan 2024 | US$1.4t | US$204.7b | -US$22,656,479,710.00 | 18.6x | -63.1x | 7x |
Thu, 28 Dec 2023 | US$1.4t | US$204.9b | -US$22,182,372,574.00 | 19.7x | -62.7x | 6.8x |
Sat, 25 Nov 2023 | US$1.2t | US$204.8b | -US$22,015,480,281.00 | 18.6x | -55.7x | 6x |
Mon, 23 Oct 2023 | US$1.2t | US$207.4b | -US$13,059,770,915.00 | 16.6x | -93.9x | 5.9x |
Wed, 20 Sep 2023 | US$1.3t | US$207.5b | -US$12,859,428,048.00 | 16.9x | -99.9x | 6.2x |
Fri, 18 Aug 2023 | US$1.3t | US$207.7b | -US$12,279,921,044.00 | 17.5x | -103.5x | 6.1x |
Sun, 16 Jul 2023 | US$1.1t | US$186.7b | -US$15,968,283,125.00 | 12.9x | -71.1x | 6.1x |
Tue, 13 Jun 2023 | US$1.2t | US$186.0b | -US$15,957,784,646.00 | 11.8x | -72.2x | 6.2x |
Thu, 11 May 2023 | US$1.2t | US$191.8b | -US$11,888,575,254.00 | 14.5x | -97.7x | 6.1x |
Sat, 08 Apr 2023 | US$1.2t | US$216.8b | -US$5,729,503,829.00 | 14x | -203x | 5.4x |
Mon, 06 Mar 2023 | US$1.2t | US$199.0b | -US$4,959,714,454.00 | 16.5x | -232.4x | 5.8x |
Wed, 01 Feb 2023 | US$1.2t | US$203.8b | US$1.8b | 15.1x | 660.3x | 5.7x |
Fri, 30 Dec 2022 | US$1.1t | US$203.4b | US$1.8b | 14.3x | 646.9x | 5.6x |
Sun, 27 Nov 2022 | US$1.1t | US$202.3b | US$1.3b | 14.6x | 845.5x | 5.6x |
Tue, 25 Oct 2022 | US$1.1t | US$206.2b | US$5.3b | 15.8x | 200.9x | 5.2x |
Thu, 22 Sep 2022 | US$1.0t | US$206.3b | US$5.7b | 14x | 179.3x | 5x |
Sat, 20 Aug 2022 | US$1.1t | US$206.4b | US$7.3b | 16x | 147.7x | 5.2x |
Mon, 18 Jul 2022 | US$1.1t | US$211.3b | US$10.6b | 17.2x | 102.8x | 5.2x |
Wed, 15 Jun 2022 | US$918.0b | US$212.1b | US$10.9b | 14.5x | 84.3x | 4.3x |
Fri, 13 May 2022 | US$938.1b | US$210.6b | US$12.5b | 12.8x | 75.3x | 4.5x |
Sun, 10 Apr 2022 | US$1.3t | US$226.8b | US$14.3b | 18.8x | 92.1x | 5.8x |
Tue, 08 Mar 2022 | US$1.2t | US$221.8b | US$10.5b | 19.1x | 114.3x | 5.4x |
Thu, 03 Feb 2022 | US$1.3t | US$212.2b | US$1.4b | 23x | 905.7x | 6x |
Sat, 01 Jan 2022 | US$1.4t | US$212.1b | US$2.8b | 25.5x | 509.6x | 6.7x |
Mon, 29 Nov 2021 | US$1.5t | US$211.9b | US$3.2b | 25x | 461x | 6.9x |
Wed, 27 Oct 2021 | US$1.5t | US$196.3b | -US$2,785,330,179.00 | 24x | -538.6x | 7.6x |
-538.6x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | 0.83% | |
Healthcare | 0.03% | |
Biotech | 0.63% | |
Biotech | 0.63% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
GILD Gilead Sciences | US$86.72 | 2.1% +US$2.2b | 11.5% | PE102.4x | |
SGEN Seagen | US$228.74 | 4.5% +US$1.8b | 76.5% | PS18.8x | |
ALNY Alnylam Pharmaceuticals | US$295.93 | 4.1% +US$1.5b | 82.9% | PS16.2x | |
GRPH Graphite Bio | US$22.26 | 539.7% +US$1.1b | 861.6% | PB7.1x | |
SMMT Summit Therapeutics | US$21.21 | 6.3% +US$939.3m | 1,046.5% | PB81.1x |